AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE889.05-8.2 (-0.91 %)
PREV CLOSE ( ) 897.25
OPEN PRICE ( ) 897.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 137674
TODAY'S LOW / HIGH ( )880.85 905.50
52 WK LOW / HIGH ( )281.15 967.6
NSE889.95-7.2 (-0.8 %)
PREV CLOSE( ) 897.15
OPEN PRICE ( ) 895.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 889.95 (50)
VOLUME 2979597
TODAY'S LOW / HIGH( ) 880.50 905.85
52 WK LOW / HIGH ( )288.85 967.5
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
01Dec Aurobindo Pharma’s arms ink pact with
Aurobindo Pharma’s wholly owned subsidiary -- Aurobindo Pharma USA, Inc...
01Dec Aurobindo Pharma jumps after its arms
Aurobindo Pharma is currently trading at Rs. 891.15, up by 23.10 points..
12Nov Aurobindo Pharma gets nod to transfer
Aurobindo Pharma’s board has approved the transfer of business undertaki..
12Nov Aurobindo Pharma soars on getting nod
Aurobindo Pharma is currently trading at Rs. 850.40, up by 39.35 points..
09Nov Biocon, Aurobindo Pharma and Cyient to
Biocon’s subsidiary company -- Biocon Biologics’ board has approved a Rs..
Financials
Rs. in Millions
QTR Jun 20 ANNUAL 20
Net Profit7146.8000000000118727.4
Gross Profit 9601.90000000001 23777
Operating Profit 10904.129437.6
Net Sales 34197132664.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
 6774.40 (1.99%)
M.Cap (Rs. in Cr)11245.09
Pfizer (BSE)
 5229.90 (2.44%)
M.Cap (Rs. in Cr)23925.61
Jubilant LifeScience (BSE)
 788.00 (8.44%)
M.Cap (Rs. in Cr)12551.35
Panacea Biotec (BSE)
 245.70 (19.33%)
M.Cap (Rs. in Cr)1504.93
Torrent Pharma (BSE)
 2687.90 (1.33%)
M.Cap (Rs. in Cr)45481.61
Shareholding Pattern
PROMOTERS 52.01%
NON-INSTITUTION 11.31%
MUTUAL FUNDS/UTI 11.02%
FI/BANKS/INSURANCE 0.17%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Sanjay Jadli, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

For Lodge the grievances click on https://scores.gov.in

Click/visit on SEBI Complaints Redress System (SCORES) for Procedure for filing of complaints on SCORES and benefits.

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.